EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Natural History and Outcomes in Paediatric RASopathy-Associated Hypertrophic Cardiomyopathy

Olga Boleti iD, Gabrielle Norrish, Ella Field, Kathleen Dady, Kim Summers, Gauri Nepali, Vinay Bhole, Orhan Uzun, Amos Wong, Piers E F Daubeney, Graham Stuart, Precylia Fernandes und 17 weitere

ESC Heart Failure · 2024

DOI: 10.1002/ehf2.14637 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ESC Heart Failure, 2024. Verfasst von Olga Boleti und 28 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Inherited Cardiovascular Diseases, Department of Cardiology, Great Ormond Street Hospital, London, UK. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Noonan Syndrome, Heart Failure. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, Medical Research Council, Alexander S. Onassis Public Benefit Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

This study aimed to describe the natural history and predictors of all-cause mortality and sudden cardiac death (SCD)/equivalent events in children with a RASopathy syndrome and hypertrophic cardiomyopathy (HCM). Methods and results This is a retrospective cohort study from 14 paediatric cardiology centres in the United Kingdom and Ireland. We included children <18 years with HCM and a clinical and/or genetic diagnosis of a RASopathy syndrome [Noonan syndrome (NS), NS with multiple lentigines (NSML), Costello syndrome (CS), cardiofaciocutaneous syndrome (CFCS), and NS with loose anagen hair (NS-LAH)]. One hundred forty-nine patients were recruited [111 (74.5%) NS, 12 (8.05%) NSML, 6 (4.03%) CS, 6 (4.03%) CFCS, 11 (7.4%) Noonan-like syndrome, and 3 (2%) NS-LAH]. NSML patients had higher left ventricular outflow tract (LVOT) gradient values [60 (36–80) mmHg, P = 0.004]. Over a median follow-up of 197.5 [inter-quartile range (IQR) 93.58–370] months, 23 patients (15.43%) died at a median age of 24.1 (IQR 5.6–175.9) months. Survival was 96.45% [95% confidence interval (CI) 91.69–98.51], 90.42% (95% CI 84.04–94.33), and 84.12% (95% CI 75.42–89.94) at 1, 5, and 10 years, respectively, but this varied by RASopathy syndrome. RASopathy syndrome, symptoms at baseline, congestive cardiac failure (CCF), non-sustained ventricular tachycardia (NSVT), and maximal left ventricular wall thickness were identified as predictors of all-cause mortality on univariate analysis, and CCF, NSVT, and LVOT gradient were predictors for SCD or equivalent event.

Conclusions

These findings highlight a distinct category of patients with Noonan-like syndrome with a milder HCM phenotype but significantly worse survival and identify potential predictors of adverse outcome in patients with RASopathy-related HCM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiomyopathy, HypertrophicNoonan SyndromeHeart FailureHumansChildRetrospective StudiesDeath, Sudden, Cardiac

Stichwörter der Autor:innen

ArrhythmiaGeneticsHypertrophic cardiomyopathyInherited cardiac conditionsMortalityNoonanPaediatric cardiologyPredictorsRASopathySudden cardiac death

Autor:innen und Institutionen

  • Centre for Inherited Cardiovascular Diseases, Department of Cardiology, Great Ormond Street Hospital, London, UK.
  • Institute of Cardiovascular Science, University College London, London, UK.
  • The Heart Unit, Birmingham Children's Hospital, Birmingham, UK.
  • Children's Heart Unit, University Hospital of Wales, Cardiff, UK.
  • Department of Paediatric Cardiology, Royal Brompton and Harefield NHS Trust, London, UK.
  • Department of Paediatric Cardiology, Bristol Royal Hospital for Children, Bristol, UK.

ORCID-Profile: Olga Boleti

Förderung

  • British Heart Foundation
  • Medical Research Council
  • Alexander S. Onassis Public Benefit Foundation
  • Max's Foundation
  • Great Ormond Street Hospital Children's Charity
  • Great Ormond Street Hospital Charity

Zitieren

APA

Boleti, O., Norrish, G., Field, E., Dady, K., Summers, K., Nepali, G., Bhole, V., Uzun, O., Wong, A., Daubeney, P. E. F., Stuart, G., Fernandes, P., McLeod, K., Ilina, M., Ali, M. N. L., Bharucha, T., Donne, G. D., Brown, E., Linter, K., …, & Kaski, J. P. (2024). Natural History and Outcomes in Paediatric RASopathy-Associated Hypertrophic Cardiomyopathy. ESC Heart Failure. https://doi.org/10.1002/ehf2.14637

Vancouver

Boleti O, Norrish G, Field E, Dady K, Summers K, Nepali G, et al. Natural History and Outcomes in Paediatric RASopathy-Associated Hypertrophic Cardiomyopathy. ESC Heart Failure. 2024. doi:10.1002/ehf2.14637

BibTeX
@article{Boleti2024,
  author = {Boleti, Olga and Norrish, Gabrielle and Field, Ella and Dady, Kathleen and Summers, Kim and Nepali, Gauri and Bhole, Vinay and Uzun, Orhan and Wong, Amos and Daubeney, Piers E F and Stuart, Graham and Fernandes, Precylia and McLeod, Karen and Ilina, Maria and Ali, Muhammad Najih Liaqath and Bharucha, Tara and Donne, Grazia Delle and Brown, Elspeth and Linter, Katie and Jones, Caroline B and Searle, Jonathan and Regan, William and Mathur, Sujeev and Boyd, Nicola and Reinhardt, Zdenka and Duignan, Sophie and Prendiville, Terence and Adwani, Satish and Kaski, Juan Pablo},
  title = {Natural History and Outcomes in Paediatric RASopathy-Associated Hypertrophic Cardiomyopathy},
  journal = {ESC Heart Failure},
  year = {2024},
  doi = {10.1002/ehf2.14637}
}
Kostenlos starten →